Cure My Disease

Don't miss your cure!

 Log in / Sign up

Better pain control after C-Section may boost breastfeeding rates

NCT ID NCT06682871

Symptom relief Sponsor: Konya City Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at 75 women who had planned cesarean deliveries to see if different pain relief methods affect how soon they start breastfeeding and whether they breastfeed exclusively. The researchers compared standard pain management with TAP blocks, a type of abdominal nerve block. The goal was to find out if better pain control helps more women breastfeed in the first hour and exclusively for the first 72 hours after birth.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Analgesia (pain relief via TAP blocks or other methods)
What this could lead to
If successful, this could show that better pain management after cesarean helps more women start breastfeeding sooner and stick with it exclusively.
What could go wrong
This is a small, completed study with only 75 participants, so results may not apply to all women. Pain relief methods vary, and other factors like personal choice also affect breastfeeding success.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

75 people

The number who actually took part.

Started

Jan 2024

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Written informed consent; * 18-45 years old; * ASA Physical Status 1-3; * Scheduled for elective cesarien delivery; * Anticipated hospitalization of at least three nights; * Expected requirement for parenteral opioids for at least 72 hours for postoperative pain; * Able to use IV PCA systems. Exclusion Criteria: * Hepatic disease, e.g. twice the normal levels of liver enzymes; * Kidney disease, e.g. twice the normal level of serum creatinine; * Bupivacaine sensitivity or known allergy; * Anticoagulants considered to be a contraindication for TAP blocks; * Surgeries with high port sites

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Analgesia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia Breast Feeding pain agnosia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Analgesia Breast feeding

Contacts and locations

Locations

  • Konya City Hospital

    Konya, 42080, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.